DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Dystroglycanopathies (DGPs) are a distinct array of CDGs that occur due to defects in the O-mannosyl glycosylation of α-dystroglycan (α-DG).